当期报告
Onconetix(ONCO)02-13 21:25
$Onconetix(ONCO)$ 8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0001213900-24-012876 Act: 34 Size: 224 KB 网页链接
简介：Onconetix, Inc.于2018年10月26日在特拉华州注册成立。该公司是一家商业阶段的生物技术公司，专注于为临床医生和患者提供肿瘤学专有疗法、诊断和服务的研究、开发和商业化。该公司目前拥有FDA批准的用于治疗良性前列腺增生（BPH）（一种前列腺疾病）的口服治疗药物EntadFi，以及用于在前列腺癌肿瘤学中筛查和诊断前列腺特异性抗原（PSA）评估不确定的男性的先进专有诊断系统Proclarix。
| 今开：0.118 | 昨收：0.1163 |
| 最高：0.118 | 最低：0.111 |
| 涨停价： | 跌停价： |
| 总市值：2614574 |
Onconetix(ONCO)02-13 21:25
$Onconetix(ONCO)$ 8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0001213900-24-012876 Act: 34 Size: 224 KB 网页链接
Onconetix(ONCO)04-09 04:15
$Onconetix(ONCO)$ 8-K Current report, item 8.01 Accession Number: 0001213900-24-031167 Act: 34 Size: 200 KB 网页链接
Onconetix(ONCO)02-15 06:15
$Onconetix(ONCO)$ PRE 14A Other preliminary proxy statements Accession Number: 0001213900-24-014146 Act: 34 Size: 4 MB 网页链接
Onconetix(ONCO)03-14 05:05
$Onconetix(ONCO)$ 8-K/A [Amend] Current report, item 9.01 Accession Number: 0001213900-24-022215 Act: 34 Size: 220 KB 网页链接
Onconetix(ONCO)04-12 04:45
$Onconetix(ONCO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001213900-24-032225 Act: 34 Size: 13 MB 网页链接
Onconetix(ONCO)04-02 04:15
$Onconetix(ONCO)$ NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 Accession Number: 0001213900-24-028725 Act: 34 Size: 25 KB 网页链接
Onconetix(ONCO)04-27 05:35
$Onconetix(ONCO)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001213900-24-036738 Act: 33 Size: 28 MB 网页链接
Onconetix(ONCO)02-15 06:15
$Onconetix(ONCO)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001213900-24-014137 Act: 33 Size: 1 MB 网页链接
Onconetix(ONCO)02-17 05:15
$Onconetix(ONCO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-24-014897 Size: 3 KB 网页链接
Onconetix(ONCO)02-22 05:15
$Onconetix(ONCO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-24-015752 Size: 5 KB 网页链接
$Onconetix(ONCO)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001213900-24-036738 Act: 33 Size: 28 MB 网页链接
$Onconetix(ONCO)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001213900-24-036645 Act: 34 Size: 288 KB 网页链接
$Onconetix(ONCO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001213900-24-032225 Act: 34 Size: 13 MB 网页链接
$Onconetix(ONCO)$ 8-K Current report, item 8.01 Accession Number: 0001213900-24-031167 Act: 34 Size: 200 KB 网页链接
$Onconetix(ONCO)$ NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 Accession Number: 0001213900-24-028725 Act: 34 Size: 25 KB 网页链接
$Onconetix(ONCO)$ 8-K/A [Amend] Current report, item 9.01 Accession Number: 0001213900-24-022215 Act: 34 Size: 220 KB 网页链接
$Onconetix(ONCO)$ 8-K/A [Amend] Current report, items 2.01, 8.01, and 9.01 Accession Number: 0001213900-24-017544 Act: 34 Size: 982 KB 网页链接
$Onconetix(ONCO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-24-015752 Size: 5 KB 网页链接
$Onconetix(ONCO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-24-014896 Size: 3 KB 网页链接
$Onconetix(ONCO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-24-014897 Size: 3 KB 网页链接